ATE517867T1 - Verbindungen, die den glutamatrezeptor verstärken und anwendungen davon in der medizin - Google Patents
Verbindungen, die den glutamatrezeptor verstärken und anwendungen davon in der medizinInfo
- Publication number
- ATE517867T1 ATE517867T1 AT06706948T AT06706948T ATE517867T1 AT E517867 T1 ATE517867 T1 AT E517867T1 AT 06706948 T AT06706948 T AT 06706948T AT 06706948 T AT06706948 T AT 06706948T AT E517867 T1 ATE517867 T1 AT E517867T1
- Authority
- AT
- Austria
- Prior art keywords
- glutama
- boost
- receptor
- medicine
- compounds
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D277/00—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings
- C07D277/60—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings condensed with carbocyclic rings or ring systems
- C07D277/62—Benzothiazoles
- C07D277/64—Benzothiazoles with only hydrocarbon or substituted hydrocarbon radicals attached in position 2
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
- C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
- C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D213/24—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with substituted hydrocarbon radicals attached to ring carbon atoms
- C07D213/36—Radicals substituted by singly-bound nitrogen atoms
- C07D213/42—Radicals substituted by singly-bound nitrogen atoms having hetero atoms attached to the substituent nitrogen atom
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
- C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
- C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D213/60—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D213/61—Halogen atoms or nitro radicals
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
- C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
- C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D213/60—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D213/62—Oxygen or sulfur atoms
- C07D213/63—One oxygen atom
- C07D213/65—One oxygen atom attached in position 3 or 5
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D317/00—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms
- C07D317/08—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3
- C07D317/44—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3 ortho- or peri-condensed with carbocyclic rings or ring systems
- C07D317/46—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3 ortho- or peri-condensed with carbocyclic rings or ring systems condensed with one six-membered ring
- C07D317/48—Methylenedioxybenzenes or hydrogenated methylenedioxybenzenes, unsubstituted on the hetero ring
- C07D317/50—Methylenedioxybenzenes or hydrogenated methylenedioxybenzenes, unsubstituted on the hetero ring with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to atoms of the carbocyclic ring
- C07D317/58—Radicals substituted by nitrogen atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D333/00—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom
- C07D333/02—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings
- C07D333/04—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom
- C07D333/06—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to the ring carbon atoms
- C07D333/14—Radicals substituted by singly bound hetero atoms other than halogen
- C07D333/20—Radicals substituted by singly bound hetero atoms other than halogen by nitrogen atoms
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GB0503155A GB0503155D0 (en) | 2005-02-15 | 2005-02-15 | Novel compounds |
GB0601612A GB0601612D0 (en) | 2006-01-26 | 2006-01-26 | Compounds |
PCT/EP2006/001342 WO2006087169A1 (en) | 2005-02-15 | 2006-02-13 | Compounds which potentiate glutamate receptor and uses thereof in medicine |
Publications (1)
Publication Number | Publication Date |
---|---|
ATE517867T1 true ATE517867T1 (de) | 2011-08-15 |
Family
ID=36253489
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
AT06706948T ATE517867T1 (de) | 2005-02-15 | 2006-02-13 | Verbindungen, die den glutamatrezeptor verstärken und anwendungen davon in der medizin |
Country Status (8)
Country | Link |
---|---|
US (1) | US7790758B2 (de) |
EP (1) | EP1848695B1 (de) |
JP (1) | JP2008530162A (de) |
AR (1) | AR054000A1 (de) |
AT (1) | ATE517867T1 (de) |
PE (1) | PE20061127A1 (de) |
TW (1) | TW200640863A (de) |
WO (1) | WO2006087169A1 (de) |
Families Citing this family (14)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP4691669B2 (ja) | 2007-08-22 | 2011-06-01 | アストラゼネカ・アクチエボラーグ | シクロプロピルアミド誘導体 |
TW201039825A (en) | 2009-02-20 | 2010-11-16 | Astrazeneca Ab | Cyclopropyl amide derivatives 983 |
TWI520945B (zh) * | 2010-02-18 | 2016-02-11 | 阿斯特捷利康公司 | 環丙基苯甲醯胺衍生物之新穎結晶形式 |
WO2013055386A2 (en) | 2011-10-03 | 2013-04-18 | The University Of Utah Research Foundation | Application of 5-ht6 receptor antagonists for the alleviation of cognitive deficits of down syndrome |
SG11201406274VA (en) * | 2012-04-27 | 2014-11-27 | Glaxo Group Ltd | Novel compounds |
US8633182B2 (en) | 2012-05-30 | 2014-01-21 | Boehringer Ingelheim International Gmbh | Indanyloxyphenylcyclopropanecarboxylic acids |
EP3311842A1 (de) | 2013-06-13 | 2018-04-25 | VeroScience LLC | Zusammensetzungen und verfahren zur behandlung von stoffwechselstörungen |
US10538490B2 (en) | 2016-10-25 | 2020-01-21 | Boehringer Ingelheim International Gmbh | Benzylaminopyridylcyclopropanecarboxylic acids, pharmaceutical compositions and uses thereof |
WO2018095877A1 (en) | 2016-11-28 | 2018-05-31 | Boehringer Ingelheim International Gmbh | Indanylaminopyridylcyclopropanecarboxylic acids, pharmaceutical compositions and uses thereof |
WO2018138029A1 (en) | 2017-01-26 | 2018-08-02 | Boehringer Ingelheim International Gmbh | Benzyloxypyridylcyclopropanecarboxylic acids, pharmaceutical compositions and uses thereof |
US10919859B2 (en) | 2017-01-26 | 2021-02-16 | Boehringer Ingelheim International Gmbh | Benzylaminopyridylcyclopropanecarboxylic acids, pharmaceutical compositions and uses thereof |
EP3573965B1 (de) | 2017-01-26 | 2021-06-23 | Boehringer Ingelheim International GmbH | Indanylaminopyrazolylcyclopropancarbonsäuren, pharmazeutische zusammensetzungen und verwendungen davon |
WO2018138028A1 (en) | 2017-01-26 | 2018-08-02 | Boehringer Ingelheim International Gmbh | Benzylaminopyrazinylcyclopropanecarboxylic acids, pharmaceutical compositions and uses thereof |
US10603317B2 (en) | 2017-01-26 | 2020-03-31 | Boehringer Ingelheim International Gmbh | Benzylaminopyridylcyclopropanecarboxylic acids, pharmaceutical compositions and uses thereof |
Family Cites Families (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
IT1276153B1 (it) * | 1995-11-17 | 1997-10-27 | Roberto Pellicciari | Derivati di glicina ad attivita' antagonista dei recettori metabotropi del glutammato |
GB9702194D0 (en) * | 1997-02-04 | 1997-03-26 | Lilly Co Eli | Sulphonide derivatives |
ZA200605247B (en) * | 2003-12-15 | 2007-10-31 | Japan Tobacco Inc | N-substituted-n-sulfonylaminocyclopropane compounds and pharmaceutical use thereof |
AU2004299455A1 (en) * | 2003-12-15 | 2005-06-30 | Japan Tobacco Inc. | Cyclopropane compounds and pharmaceutical use thereof |
EP1786769A1 (de) * | 2004-08-09 | 2007-05-23 | Glaxo Group Limited | Verbindungen, die den glutamatrezeptor verstärken und anwendungen davon in der medizin |
-
2006
- 2006-02-13 EP EP06706948A patent/EP1848695B1/de active Active
- 2006-02-13 JP JP2007555519A patent/JP2008530162A/ja active Pending
- 2006-02-13 WO PCT/EP2006/001342 patent/WO2006087169A1/en active Application Filing
- 2006-02-13 TW TW095104677A patent/TW200640863A/zh unknown
- 2006-02-13 US US11/816,284 patent/US7790758B2/en not_active Expired - Fee Related
- 2006-02-13 PE PE2006000161A patent/PE20061127A1/es not_active Application Discontinuation
- 2006-02-13 AT AT06706948T patent/ATE517867T1/de not_active IP Right Cessation
- 2006-02-15 AR ARP060100542A patent/AR054000A1/es not_active Application Discontinuation
Also Published As
Publication number | Publication date |
---|---|
US20080167351A1 (en) | 2008-07-10 |
EP1848695A1 (de) | 2007-10-31 |
AR054000A1 (es) | 2007-05-30 |
TW200640863A (en) | 2006-12-01 |
WO2006087169A1 (en) | 2006-08-24 |
PE20061127A1 (es) | 2006-10-21 |
US7790758B2 (en) | 2010-09-07 |
EP1848695B1 (de) | 2011-07-27 |
JP2008530162A (ja) | 2008-08-07 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
ATE434608T1 (de) | Verbindungen, die den glutamatrezeptor verstärken und anwendungen davon in der medizin | |
ATE517867T1 (de) | Verbindungen, die den glutamatrezeptor verstärken und anwendungen davon in der medizin | |
ATE532511T1 (de) | Sterile formulierungen, welche die immunantwort modifizieren, und verfahren | |
DE602005020310D1 (de) | Lanzette, lanzettenanordnung und lanzette-sensor-kombination | |
BRPI0815773A2 (pt) | composto, e, medicamento. | |
DE602006021169D1 (de) | Spiroheterocyclische verbindungen und ihre anwendungen als therapeutische mittel | |
DE602006005539D1 (de) | Ernährungsschlauch und Schiene | |
TWI316304B (en) | Transistor element, display device and these manufacturing methods | |
IL189439A0 (en) | Cyclic nitro compounds, pharmaceutical compositions thereof and uses thereof | |
DE602006001275D1 (de) | Gassack und Gassackeinrichtung | |
DE602006011234D1 (de) | Airbag und Airbagvorrichtung | |
DE602006019119D1 (de) | Verbindungen mit aktivität am m1-rezeptor und ihre verwendung in der medizin | |
DE602006010343D1 (de) | Kombinationsprodukt aus o-desmethylvenlafaxin und bazedoxifen und verwendungen davon | |
DE602006005104D1 (de) | Luftsack und Luftsackvorrichtung | |
BRPI0815578A2 (pt) | Peptídeo de cdca1 e agente farmacêutico compreendendo o mesmo. | |
DE602006002000D1 (de) | Gassack und Gassackeinrichtung | |
BRPI0815577A2 (pt) | Peptídeo foxm1 e agente medicinal compreendendo o mesmo. | |
DE602005012598D1 (de) | Imidazoä1,2-aüpyridinverbindungen, zusammensetzungen, anwendungen und verfahren, die damit in zusammenhang stehen | |
DE602006011786D1 (de) | Fluidproduktabgabeglied und damit versehene abgabevorrichtung | |
ATE442368T1 (de) | 3-amino-2-arylpropylazaindole und anwendungen davon | |
DE602004028875D1 (de) | Turboladergehäuse, turbolader und multiturboladersystem | |
DE602006009359D1 (de) | Halbleiter-Vorrichtung, Motor und Motorsteuerung, die diese enthält | |
EP1857173A4 (de) | Strömungseinstellungsvorrichtung, mikroreaktor und verwendung davon | |
DE602005020457D1 (de) | Master-slave-flip-flop, trigger-flip-flop und zähler | |
ATE500217T1 (de) | Fluorhaltige organoschwefelverbindung und pestizidzusammensetzung, die diese enthält |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
RER | Ceased as to paragraph 5 lit. 3 law introducing patent treaties |